Literature DB >> 21303641

Blood glucose testing in the hospital: error sources and risk management.

James H Nichols1.   

Abstract

Glucose testing in the hospital with point-of-care devices presents multiple opportunities for error. Any device can fail under the right conditions. For glucose monitoring in the hospital, with thousands of operators, hundreds of devices, and dozens of locations involved, there is ample opportunity for errors that can impact the quality of test results. Errors can occur in any phase of the testing process: preanalytic, analytic, or postanalytic. Common sources of meter error include patient or methodology interferences, operator mistakes, environmental exposure, and device malfunction. Early models of glucose meters had few internal checks or capability to warn the operator of meter problems. The latest generation of glucose monitors has a number of internal checks and controls engineered into the testing process to prevent serious errors or warn the operator by suppressing test results. Some of these control processes are built into the software and data management system of the meters, others require the hospital to do something, such as regularly clean the meter or analyze control samples of known glucose concentration, to verify meter performance. Hospitals need to be aware of the potential for errors by understanding weaknesses in the testing process that could lead to erroneous results and take steps to prevent errors from occurring or to minimize the harm to patients when errors do occur. The reliability of a glucose result will depend on the balance of internal control features available from manufacturers in conjunction with the liquid control analysis and other control processes (operator training, device validation, and maintenance) utilized by the hospitals.
© 2010 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21303641      PMCID: PMC3045236          DOI: 10.1177/193229681100500124

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  4 in total

1.  We need tighter regulatory standards for blood glucose monitoring, but they should be for accuracy disclosure.

Authors:  Barry H Ginsberg
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose.

Authors:  David C Klonoff; Joseph F Perz
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

3.  Reducing medical errors through barcoding at the point of care.

Authors:  James H Nichols; Cathy Bartholomew; Mary Brunton; Carlos Cintron; Sheila Elliott; Joan McGirr; Deborah Morsi; Sue Scott; Joseph Seipel; Daisy Sinha
Journal:  Clin Leadersh Manag Rev       Date:  2004 Nov-Dec

4.  Blood glucose measurement in patients with suspected diabetic ketoacidosis: a comparison of Abbott MediSense PCx point-of-care meter values to reference laboratory values.

Authors:  Fidela S J Blank; Moses Miller; James Nichols; Howard Smithline; Gillian Crabb; Penelope Pekow
Journal:  J Emerg Nurs       Date:  2008-06-30       Impact factor: 1.836

  4 in total
  9 in total

Review 1.  Challenges of inpatient blood glucose monitoring: standards, methods, and devices to measure blood glucose.

Authors:  Kathie L Hermayer; Aundrea S Loftley; Sumana Reddy; Satya Nandana Narla; Nina A Epps; Yusheng Zhu
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

2.  Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital.

Authors:  Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

Review 3.  Point-of-care blood glucose testing for diabetes care in hospitalized patients: an evidence-based review.

Authors:  Rajesh Rajendran; Gerry Rayman
Journal:  J Diabetes Sci Technol       Date:  2014-06-05

4.  Development and Validation of a Rapid (13)C6-Glucose Isotope Dilution UPLC-MRM Mass Spectrometry Method for Use in Determining System Accuracy and Performance of Blood Glucose Monitoring Devices.

Authors:  Risë K Matsunami; Kimon Angelides; David A Engler
Journal:  J Diabetes Sci Technol       Date:  2015-05-18

5.  Effective interventions to improve the quality of critically high point-of-care glucose meter results.

Authors:  Julie Lv Shaw; Christopher R McCudden; David A Colantonio; Ronald A Booth; Danny C Lin; Ivan M Blasutig; Thomas Moran; Dana Trofimczuk; Chantal Carriere; Anas Gharra; Cheryl Portelance; Chantal Tremblay; Dianne Dupaul; Nathalie Breton; Merina Angelkovski; Chetan Jariwala; Maureen Embleton; Christine Campbell; Kristina Groulx; Karen Larmour
Journal:  Pract Lab Med       Date:  2020-10-19

6.  Six Sigma performance of quality indicators in total testing process of point-of-care glucose measurement: A two-year review.

Authors:  Anne Vincent; Donnah Pocius; Yun Huang
Journal:  Pract Lab Med       Date:  2021-03-19

7.  Results of a survey among GP practices on how they manage patient safety aspects related to point-of-care testing in every day practice.

Authors:  Claudette de Vries; Carine Doggen; Ellen Hilbers; Robert Verheij; Maarten IJzerman; Robert Geertsma; Ron Kusters
Journal:  BMC Fam Pract       Date:  2015-02-05       Impact factor: 2.497

8.  Use of portable blood physiology point-of-care devices for basic and applied research on vertebrates: a review.

Authors:  Lauren J Stoot; Nicholas A Cairns; Felicia Cull; Jessica J Taylor; Jennifer D Jeffrey; Félix Morin; John W Mandelman; Timothy D Clark; Steven J Cooke
Journal:  Conserv Physiol       Date:  2014-04-04       Impact factor: 3.079

9.  LabWAS: Novel findings and study design recommendations from a meta-analysis of clinical labs in two independent biobanks.

Authors:  Jeffery A Goldstein; Joshua S Weinstock; Lisa A Bastarache; Daniel B Larach; Lars G Fritsche; Ellen M Schmidt; Chad M Brummett; Sachin Kheterpal; Goncalo R Abecasis; Joshua C Denny; Matthew Zawistowski
Journal:  PLoS Genet       Date:  2020-11-11       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.